Indegene’s IPO Gets Bumper Response From Investors

  •  3 min read
  • 0
  • 07 May 2024
Indegene’s IPO Gets Bumper Response From Investors

Key Highlights:

  • IPO of Indegene Ltd has been subscribed 1.67 times at the end of day one
  • Strong financials, robust client relationships, and domain expertise have contributed to investors' confidence
  • The company's IPO consists of fresh issue and offer for sale

The much-awaited initial public offering of Indegene Ltd has opened for investors to subscribe. On expected lines, the IPO is already a run-away hit among investors as it has been subscribed 1.67 times at the end of day one. Offering digital-led commercial services for the life sciences industry, the IPO consists of a fresh issue of 1,68,14,159 shares with an offer for sale constituting 2,39,32,732 shares.

The subscription number Indegene IPO reflects investors' interest in the company's prospects. The subscription shows that investors believe in the company's business model and ability to generate returns. It shows the company's value proposition and its potential for future success.

Given below are some possible reasons behind investors’ enthusiasm leading to this subscription:

  • A dominant player in its domain
    The company is a dominant player in the healthcare domain. It has won several awards for its services.

  • Strong financials
    The company boasts strong financials, with key financial metrics like profit after tax, net revenues, return on equity, and profit after tax, recording growth over the years.

  • Robust client relationships
    The company enjoys robust client relationships with attractive retention rates. This has had a positive impact on its revenues and operations.

  • Global delivery model
    The company's global delivery model, which spans Asia, North America, and Europe, has helped it expand and strengthen its clientele.

Wrapping it up

Indegene Ltd’s IPO will close on 8th May. If you want to subscribe to the company's IPO, apply for the shares on or before it. With the life sciences industry poised to grow significantly in the coming years, adding shares of Indegene Ltd in your portfolio can help bolster your portfolio's returns. Happy investing!

Disclaimer: This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.

Investments in securities market are subject to market risks, read all the related documents carefully before investing. Please read the SEBI prescribed Combined Risk Disclosure Document prior to investing. Brokerage will not exceed SEBI prescribed limit.

Source: RHP

Money Control

Zee Business

Many new IPOs are performing well these days, presenting good opportunities for investors. Some IPOs that have created a buzz among investors are about to launch between May 8th - May 10th.

Click the below link to know more about upcoming IPOs:

Aadhar Housing Finance IPO



The issue price band of Indegene Ltd's IPO is Rs 430 - Rs 452

The lot size of the IPO is 33 shares.

13th May is the listing date of Indegene Ltd.

Enjoy Zero brokerage on ALL Intraday Trades
+91 -